Corrigendum: miR-21 in Human Cardiomyopathies

Front Cardiovasc Med. 2022 Apr 25:9:913429. doi: 10.3389/fcvm.2022.913429. eCollection 2022.

Authors

Surina¹, Rosaria Anna Fontanella¹, Lucia Scisciola¹, Raffaele Marfella^{1

2}, Giuseppe Paolisso^{1

2}, Michelangela Barbieri¹

Affiliations

¹ Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
² Mediterrannea Cardiocentro, Napoli, Italy.

Abstract

[This corrects the article DOI: 10.3389/fcvm.2021.767064.].

Keywords: biomarkers; cardiomyopathies; fibrosis; miR-21; targeted therapy.

Copyright © 2022 Surina, Fontanella, Scisciola, Marfella, Paolisso and Barbieri.

Publication types

Published Erratum